Four-Part Talk Ten Tuesday Series “Vaccination Nation” Debuts

By
Original story posted on: February 1, 2021

The series will highlight the dangers of vaccination hesitancy, which is causing concern among health experts hopeful for herd immunity from COVID-19.

In response to deep concern over widespread “vaccination hesitancy” – an issue the World Health Organization (WHO) says is one of the top 10 global health threats – ICD10monitor and Talk-Ten-Tuesdays are jointly producing a four-part series, “Vaccination Nation,” with the first installment part of today’s regularly scheduled Talk-Ten-Tuesdays Internet radio broadcast.

The series, the brainchild of Erica Remer, MD, cohost of the broadcast, and Chuck Buck, publisher of ICD10monitor and executive producer of Talk Ten Tuesdays, is intended to generate awareness of the need to be vaccinated while correcting misinformation and mitigating fears that contribute to hesitancy.

“We recognize the imminent peril our nation faces during the current pandemic, due in part to a resistance by many to be vaccinated against this deadly virus,” Buck said. “Dr. Anthony Fauci, Chief Medical Adviser to the President and director of the National Institute of Allergy and Infectious Diseases, is reported to have said herd immunity might not be achieved until 90 percent of the population has been vaccinated.”

Buck added that he is hoping readers and listeners will share information presented each Tuesday in February with friends, colleagues, and family members. “Maybe we can generate a critical mass so that we could say February is Vaccine Month,” he said.

The Talk Ten Tuesdays February lineup includes the following episodes, the topics of which will also be covered in ICD10monitor, the long-running weekly online news service for hospitals and physician practices:

Part I:  Feb. 2, 2021: The Launch
The four-part series will be launched within the existing Talk Ten Tuesdays program format. During this initial broadcast, Dr. Remer will conduct a listener’s poll, asking those tuning in to describe their concerns about being vaccinated. She will use the results of the poll as a springboard to make the case for the imperative to be vaccinated.

Part II:  Feb. 9, 2021: The Response
In a departure from its customary format, this edition of Talk Ten Tuesdays will be a Town Hall discussion, during which Dr. Remer will answer listeners’ questions compiled from the previous week’s broadcast.
 
Part III:  Feb. 16, 2021: The Inoculators
This broadcast will recognize contributions made to the nation’s vaccination rollout by having several inoculators appear, including Dr. Remer and Dr. John Foggle – a frontline physician who, in addition to treating patients, has been inoculating residents in his hospital’s service area in Rhode Island. Also participating will be Lynne Comstock, PharmD.

Part IV:  Feb. 23,  2021: The Update
The final portion of the series will feature dispatches from various ICD10monitor contributors and Talk Ten Tuesdays panelists who will provide updates on vaccination rates from their respective states.

“We are encouraging our readers and listeners to submit any and all questions they might have concerning this topic” Buck said. “This vaccination effort reminds me somewhat of early efforts that general media took to mobilize Americans to rally around a cause associated with current events. This current event is really a matter of life and death.”

The global COVID-19 pandemic has now resulted in more than 100 million cases worldwide, as well as 2.23 million deaths. Nearly 27 million of those cases and more than 450,000 deaths have occurred in the U.S. alone.

Two companies, Moderna and Pfizer, have had their COVID vaccines approved for use by the Food and Drug Administration (FDA). Since vaccine distribution began in the U.S. in mid-December 2020, more than 29 million doses have been administered, reaching 7.2 percent of the total U.S. population, according to federal data collected by the Centers for Disease Control and Prevention (CDC) and reported on by NPR.

A third company, Johnson & Johnson, is expected to apply for FDA approval for its single-dose vaccine shortly, and company officials have said they will be able to produce 100 million doses by June. Officials with both Moderna and Pfizer have reportedly said that they plan to have produced 200 million doses apiece by the summer.

To submit a question or comment, use this link:

 

 

Mark Spivey

Mark Spivey is a national correspondent for ICDmonitor.com who has been writing on numerous topics facing the nation’s healthcare system (and federal oversight of it) for five years.

Related Stories

  • Integrating COVID-19 into Coding and Clinical Documentation Integrity
    There are certain key elements of consideration during CDI review of COVID-19 patients.  Understanding how to clinically validate sepsis and differentiate between sepsis and septicemia is not easy, and requires a lot of time and effort. Sepsis is an overwhelming…
  • CODING COVID-19 Vaccination
    Vaccination coding and billing questions answered. COVID-19 vaccination is ramping up. We recently wrapped up Vaccination Nation, our special-edition four-part series on Talk Ten Tuesdays, at the end of February. I have been fielding questions about COVID-19 vaccination coding and…
  • CMS Moves to Streamline Coverage and Reimbursement for COVID Testing and Vaccination
    Federal officials are ordering plans and insurers to cover testing without cost-sharing – for virtually any purpose. Federal officials have issued new guidance intended to streamline the process through which Americans can get easy, free access to COVID-19 diagnostic testing…